# Evaluation of the Effect of Pramlintide on Satiety and Food Intake

> **NCT00042601** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 51 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Pramlintide acetate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00042601
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2003-10
- **Final completion:** 2003-10
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00042601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00042601, "Evaluation of the Effect of Pramlintide on Satiety and Food Intake". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00042601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*